We are live on
!
Find out more
RA
Royce & Associates Portfolio holdings
AUM
$12.4B
1-Year Est. Return
64.17%
This Fund
S&P 500
This Quarter
Est. Return
+28.76%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$12.4B
AUM Growth
+$2.29B
(+23%)
Cap. Flow
-$8.07M
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
9.07%
Holding
848
New
74
Increased
361
Reduced
233
Closed
101
Avg Time Held
18.2
quarters
Top 10 Avg Time Held
3.2
quarters
Top 20 Avg Time Held
7.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$43.3M |
| 2 |
Mine Safety
MSA
|
+$37.1M |
| 3 |
Yesway Inc
YSWY
|
+$34.7M |
| 4 |
Dorman Products
DORM
|
+$24.6M |
| 5 |
Avantor
AVTR
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cohu
COHU
|
+$54.5M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
+$51.1M |
| 3 |
MKS Inc
MKSI
|
+$44.5M |
| 4 |
Vishay Intertechnology
VSH
|
+$40.2M |
| 5 |
Littelfuse
LFUS
|
+$35.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 26.88% |
| 2 | Technology | 19.45% |
| 3 | Financials | 14.84% |
| 4 | Consumer Discretionary | 12.86% |
| 5 | Healthcare | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
351
DELISTED
Catalyst Pharmaceutical
CPRX
| $11.3M | 0.09% |
358,642
-1,731,264
| -83% | -$51.1M |
2019 Q4
26 quarters
|
|
352
Kirby Corp
KEX
$7.17B
| $11.2M | 0.09% |
82,705
-19,573
| -19% | -$2.8M |
2015 Q4
42 quarters
|
|
353
Armstrong World Industries
AWI
$6.84B
| $11.2M | 0.09% |
+70,023
| New | +$11.4M |
2026 Q2
0 quarters
|
|
354
VanEck Junior Gold Miners ETF
GDXJ
$8.37B
| $11.2M | 0.09% |
114,000
+25,242
| +28% | +$2.93M |
2015 Q3
43 quarters
|
|
355
Hawkins
HWKN
$2.72B
| $11.1M | 0.09% |
78,257
-425
| -0.5% | -$67.2K |
2013 Q2
52 quarters
|
|
356
Photronics
PLAB
$1.73B
| $11.1M | 0.09% |
341,476
-32,157
| -9% | -$1.36M |
2013 Q2
52 quarters
|
|
357
Civista Bancshares
CIVB
$555M
| $11M | 0.09% |
391,417
-1,943
| -0.5% | -$49.3K |
2025 Q3
3 quarters
|
|
358
Lear
LEA
$5.78B
| $11M | 0.09% |
82,386
-695
| -0.8% | -$93.1K |
2024 Q4
6 quarters
|
|
359
Titan International
TWI
$442M
| $11M | 0.09% |
1,428,798
+138,980
| +11% | +$1.07M |
2023 Q2
12 quarters
|
|
360
Gold Fields
GFI
$32.7B
| $11M | 0.09% |
326,500
| – | – |
2013 Q2
52 quarters
|
|
361
Gentex
GNTX
$4.36B
| $11M | 0.09% |
433,406
+30,046
| +7% | +$711K |
2025 Q2
4 quarters
|
|
362
ePlus
PLUS
$2.48B
| $10.9M | 0.09% |
130,540
+12,149
| +10% | +$1.01M |
2020 Q1
25 quarters
|
|
363
Insteel Industries
IIIN
$579M
| $10.7M | 0.09% |
354,368
+132,980
| +60% | +$3.81M |
2013 Q2
52 quarters
|
|
364
Target Hospitality
TH
$1.84B
| $10.7M | 0.09% |
523,941
| – | – |
2025 Q4
2 quarters
|
|
365
Advanced Energy
AEIS
$11.2B
| $10.7M | 0.09% |
28,576
-8,600
| -23% | -$3.01M |
2013 Q2
52 quarters
|
|
366
Teleflex
TFX
$5.33B
| $10.7M | 0.09% |
84,040
+28,510
| +51% | +$3.65M |
2025 Q3
3 quarters
|
|
367
MasterCraft Boat Holdings
MCFT
$467M
| $10.6M | 0.09% |
411,897
+30,805
| +8% | +$717K |
2015 Q3
43 quarters
|
|
368
Babcock & Wilcox
BW
$746M
| $10.6M | 0.09% |
753,180
+93,180
| +14% | +$1.58M |
2025 Q4
2 quarters
|
|
369
Oric Pharmaceuticals
ORIC
$1.22B
| $10.6M | 0.09% |
979,664
-227,559
| -19% | -$2.06M |
2025 Q2
4 quarters
|
|
370
Legacy Education Inc
LGCY
$132M
| $10.5M | 0.08% |
896,387
+65,929
| +8% | +$776K |
2024 Q3
7 quarters
|
|
371
John B. Sanfilippo & Son
JBSS
$788M
| $10.5M | 0.08% |
122,000
-61,161
| -33% | -$4.84M |
2013 Q2
52 quarters
|
|
372
Western New England Bancorp
WNEB
$274M
| $10.5M | 0.08% |
731,557
-6,540
| -0.9% | -$89.3K |
2015 Q1
45 quarters
|
|
373
EVI Industries
EVI
$240M
| $10.4M | 0.08% |
703,990
-185,901
| -21% | -$3.42M |
2016 Q4
38 quarters
|
|
374
FIVE9
FIVN
$2.67B
| $10.4M | 0.08% |
+485,862
| New | +$9.59M |
2026 Q2
0 quarters
|
|
375
Inseego
INSG
$75.6M
| $10.3M | 0.08% |
997,014
+192,569
| +24% | +$2.58M |
2025 Q3
3 quarters
|
|
Similar funds
JF
WRCM
LC
AIM
SC
ERSOT
BAMF
Royce & Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Royce & Associates held 848 positions worth $12.4B, up 23% from $10.1B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Royce & Associates's Q2 2026 filing shows 74 new, 361 increased, 233 reduced and 101 closed positions. Its largest new stake was Manhattan Associates: 314,304 shares worth $43.8M. The largest sale was Cohu, an estimated $54.5M.
By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- Royce & Associates's largest Q2 2026 buy was Manhattan Associates: 314,304 shares worth $43.8M.
- Royce & Associates added most to Mine Safety in Q2 2026, an estimated $37.1M increase.
- Royce & Associates's biggest Q2 2026 reduction was Cohu, cutting an estimated $54.5M.
- Royce & Associates fully exited Transmedics in Q2 2026, selling an estimated $24.3M.
- Royce & Associates's ten largest holdings make up 9.1% of its $12.4B portfolio in Q2 2026.
- Royce & Associates opened 74 new positions and closed 101 in Q2 2026.
- Royce & Associates's portfolio value rose 23% quarter-over-quarter to $12.4B.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.